AVXL

New York, New York--(Newsfile Corp. - November 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Suit alleges Anavex Life Sciences Corp. failed to disclose key facts to investors from November 26, 2025 through August 28, 2026; lead plaintiff deadline is November 30, 2026 BENSALEM TOWNSHIP, Pa., Nov. 6, 2026 /PRNewswire/ -- The Law Offices of Howard G.

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Anavex (AVXL) To Contact Him Directly To Discuss Their Options

Lawsuit alleges Anavex Life Sciences Corp. made misleading statements to investors from November 26, 2025 to August 28, 2026; lead plaintiff motions are due November 30, 2026 LOS ANGELES, Nov. 5, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) on behalf of investors who acquired the Company's securities from November 26, 2025 to August 28, 2026.

Nationally Recognized Firm Urges Anavex Investors to Explore Class Action Representation Lead Plaintiff Deadline: November 30, 2026. Investors who purchased (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 may be eligible to recover losses.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 5, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Anavex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Anavex between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 4, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL) and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

New York, New York--(Newsfile Corp. - November 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Anavex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Investors in Fluence Energy, Inc., Qfin Holdings, Inc., Endava plc, and Anavex Life Sciences Corp. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions Investors in Fluence Energy, Inc., Qfin Holdings, Inc., Endava plc, and Anavex Life Sciences Corp. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions